cinacalcet has been researched along with raloxifene hydrochloride in 4 studies
| Studies (cinacalcet) | Trials (cinacalcet) | Recent Studies (post-2010) (cinacalcet) | Studies (raloxifene hydrochloride) | Trials (raloxifene hydrochloride) | Recent Studies (post-2010) (raloxifene hydrochloride) |
|---|---|---|---|---|---|
| 1,070 | 155 | 627 | 2,818 | 481 | 810 |
| Protein | Taxonomy | cinacalcet (IC50) | raloxifene hydrochloride (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0053 | |
| Gastric inhibitory polypeptide receptor | Homo sapiens (human) | 0.0004 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1297 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farford, B; Moraghan, TJ; Presutti, RJ | 1 |
| Dillon, ML; Frazee, LA | 1 |
| Eriguchi, M; Haruyama, N; Kitazono, T; Nakano, T; Tanaka, S; Taniguchi, M; Tsuruya, K; Yamada, S; Yoshida, H | 1 |
| Alfadhli, EM | 1 |
3 review(s) available for cinacalcet and raloxifene hydrochloride
| Article | Year |
|---|---|
Nonsurgical management of primary hyperparathyroidism.
Topics: Cinacalcet; Diet; Diphosphonates; Estrogen Replacement Therapy; Humans; Hyperparathyroidism, Primary; Life Style; Naphthalenes; Raloxifene Hydrochloride; Sclerotherapy; Selective Estrogen Receptor Modulators | 2007 |
Cinacalcet for the treatment of primary hyperparathyroidism.
Topics: Bone Density; Bone Density Conservation Agents; Calcimimetic Agents; Calcitonin; Cinacalcet; Diphosphonates; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hyperparathyroidism, Primary; Naphthalenes; Osteoporosis; Raloxifene Hydrochloride | 2011 |
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic.
Topics: Bone Density; Calcium; Cinacalcet; COVID-19; Diphosphonates; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Parathyroidectomy; Raloxifene Hydrochloride; Vitamin D | 2021 |
1 other study(ies) available for cinacalcet and raloxifene hydrochloride
| Article | Year |
|---|---|
The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
Topics: Acid Phosphatase; Acute Kidney Injury; Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Cinacalcet; Collagen Type I; Cross-Sectional Studies; Female; Humans; Hydroxycholecalciferols; Isoenzymes; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptides; Peritoneal Dialysis; Raloxifene Hydrochloride; Regression Analysis; Tartrate-Resistant Acid Phosphatase | 2013 |